Dr. Powell on Important Future Directions in Lung Cancer

Charles Powell, MD
Published: Wednesday, Sep 28, 2016



Charles Powell, MD, director, Mount Sinai-National Jewish Health Respiratory Institute, sheds light on what he feels oncologists should be tackling in the future of treating patients with lung cancer in an interview during the IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology.

Powell discusses the importance of managing patients with pulmonary nodules in a systematic and standardized way, given that there is an increased prevalence as a result of CT screening.

He also urges oncologists in this space to take what they are learning about advanced lung cancer and apply it to early-stage disease, as the cure rates have been shown to be much higher in that patient population.


Charles Powell, MD, director, Mount Sinai-National Jewish Health Respiratory Institute, sheds light on what he feels oncologists should be tackling in the future of treating patients with lung cancer in an interview during the IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology.

Powell discusses the importance of managing patients with pulmonary nodules in a systematic and standardized way, given that there is an increased prevalence as a result of CT screening.

He also urges oncologists in this space to take what they are learning about advanced lung cancer and apply it to early-stage disease, as the cure rates have been shown to be much higher in that patient population.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x